Adverse Drug Event Clinical Trials

73 clinical trials for Adverse Drug Event across international registries, including 8 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Efficacy and Safety of Remimazolam Besylate for Sedation in Post-Non-Cardiac Surgery Patients Requiring Mechanical Ventilation — RECRUITING · PHASE4
• Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia — RECRUITING
• Melatonin for Prevention of Kidney Injury — RECRUITING · PHASE3
• Comparative Study of Tranexamic Acid Dosing in Cardiac Surgery — RECRUITING · NA
• Evaluation of the Implementation of the Pharmacogenetics and Personalized Medicine Program "MedeA" in the Extremadura Health Service. — RECRUITING
• Oncolytic Virus Ad-TD-nsIL12 for Primary Pediatric Diffuse Intrinsic Pontine Glioma — RECRUITING · PHASE1
• Oncolytic Virus Ad-TD-nsIL12 for Progressive Pediatric Diffuse Intrinsic Pontine Glioma — RECRUITING · PHASE1
• Effect of NST Whole-course Nutritional Management on Nutritional Status and Adverse Reactions in Esophageal Cancer — RECRUITING · NA
• Safety of Pediatric COVID-19 Vaccination — COMPLETED
• Effectiveness of an ADE-related Hospitalization Risk Prediction Tool for Patients (ADE-RED) — COMPLETED
• MEOP - Multidimensional Evaluations in Oncological Psychiatry — NOT_YET_RECRUITING
• A Study of GC101 TIL in Advanced Melanoma (BZ) — COMPLETED · PHASE1
• Reducing High-Risk Geriatric Polypharmacy Via EHR Nudges: Pilot Phase — WITHDRAWN · NA
• A Phase I Study of GC101 TIL in Advanced Solid Tumors — COMPLETED · PHASE1
• NOCDURNA PASS Study Using Registries in Denmark, Germany and Sweden — COMPLETED
• Peppermint Oil for the Treatment of Irritable Bowel Syndrome or Functional Abdominal Pain in Children: the MINT Study — COMPLETED · PHASE3
• NUDGE-EHR Replication Trial at Mass General Brigham — COMPLETED · NA
• Optimizing Electronic Health Record Prompts With Behavioral Economics to Improve Prescribing for Older Adults — COMPLETED · NA
• Impact of a Pharmacovigilance Program Led by Advanced Practice Nursing — COMPLETED · NA
• Active Pharmacovigilance Study of the Medicine Rinvoq™ (Upadacitinib) — OTHER
• Simultaneous RZV and aIIV4 Vaccination — COMPLETED · PHASE4
• Collaborative Nurse-pharmacist Counseling for Self-administered Biologics — WITHDRAWN · NA
• Over-the-counter (OTC) Labels for Older Adults — COMPLETED · NA
• Simultaneous mRNA COVID-19 and IIV4 Vaccination Study — COMPLETED · PHASE4
• Dolutegravir and Clinical Outcomes Among ART-recipients in Brazil — OTHER
• QSPainRelief-STRAT — OTHER · NA
• TIL and Anti-PD1 in Metastatic Melanoma — OTHER · PHASE1
• Effect of Salovum™ and SPC-Flakes™ on Abemaciclib-induced Gastrointestinal Toxicity in Early Breast Cancer — OTHER · PHASE3
• MedSafer E-care: an Automated Deprescribing Solution (E-CARE Study) — WITHDRAWN · NA
• Oliceridine in Patients With Acute Burn Injuries — COMPLETED · PHASE4
• Regional Data Exchange to Improve Care for Veterans After Non-VA Hospitalization — COMPLETED · NA
• Monitoring the Antiphospholipid Syndrome:TOXicity of Drugs (APSTOX) — COMPLETED
• Monitoring the Hyperammonaemia:TOXicity of Drugs (AmmoTOX) — COMPLETED
• Pharmacogenomic Analysis in Pediatric Acute Lymphoblastic Leukemia — COMPLETED
• Research on Human Insulin rDNA Safety and Efficacy in Patients With Type 2 Diabetes Mellitus — COMPLETED · PHASE4
• Implementation of a Pharmacist-led Pharmacogenomic Clinical Service — WITHDRAWN
• Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With Polypharmacy — COMPLETED
• Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines. — COMPLETED
• Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Adults With Polypharmacy Using Data From Large Medicare and Commercially Insured Populations — OTHER
• Medication Reconciliation Using Electronic Pharmaceutical Record: A Multicenter Study in the Hospitalized Elderly — COMPLETED · NA
• Impact of an Optimized Communication on the Readmission for Adverse Drug Event — COMPLETED · NA
• Adverse Reactions Following COVID-19 Vaccination Among Ecuadorian Healthcare Workers — COMPLETED
• Drug-Related Problems in Neonatal Patients — OTHER · NA
• Post-marketing Safety Surveillance of Xueshuantong-Injection : a Registry Study — OTHER
• Spread and Scale of a Polypharmacy App — OTHER · NA
• Reducing Post-discharge Adverse Drug Events Amongst the Elderly: a Multi-centre Electronic Deprescribing Intervention — COMPLETED · NA
• Rheumatologic Adverse Events and Cancer Immunotherapy — OTHER · NA
• Post-marketing Safety Surveillance of Breviscapine Powder-Injection : a Registry Study — SUSPENDED
• FLUAD® vs. Fluzone® High-Dose Study — COMPLETED · PHASE4
• PAINTER: Polymorphism And INcidence of Toxicity in ERibulin Treatment — COMPLETED · PHASE4

Refine this search